Navigation Links
Breakthrough Isolaz(TM) Acne Therapy Featured in U.S. News & World Report:
Date:6/10/2008

Aesthera Isolaz Therapy described as 'Advance Against Acne'

PLEASANTON, Calif., June 10 /PRNewswire/ -- Aesthera Corporation's Isolaz(TM) painless acne therapy has been featured in the June 9, 2008, issue of U.S. News & World Report, a leading national weekly news magazine. The publication describes Isolaz(TM) acne therapy as "an advance against acne" and reports that the Isolaz is the first treatment device FDA cleared to treat comedonal and pustular acne, in addition to mild to moderate, inflammatory acne and acne vulgaris.

Discussing clinical outcomes, the article explains the Isolaz(TM) system's effectiveness on patients of all ages, who have struggled with acne and have failed traditional therapies including topicals and antibiotics. Gilly Munavalli, MD, MHS, Director of Dermatology, Laser, and Veins Specialists of the Carolinas in Charlotte, NC and Clinical Instructor of Dermatology at Johns Hopkins University School of Medicine, notes that while the Isolaz also works on non-responders to traditional acne therapies, a greater benefit of the treatment is the rapid improvement relative to drugs.

The article describes a 22-year-old patient's struggle with acne and her 100% clinical, emotional and functional improvement post Isolaz(TM) treatments. Dermatologist Dale Isaacson, MD expresses great satisfaction with Isolaz system's efficacy noting that the device works in about 90% of his patients.

In addition to this breakthrough painless therapy for acne, Aesthera's Isolaz(TM) system is also FDA cleared to treat skin rejuvenation, including the treatment of vascular and pigmented lesions as well as hair removal on all skin types.

Prior to its coverage by U.S. News & World Report, Isolaz(TM) therapy has also been recently featured in the New York Times and Wall Street Journal. It has also been covered by Vogue, Elle, Allure, Shape, Bazaar, Self, and the June 2008 issues of Marie Claire and Family Circle, as a breakthrough acne treatment that also successfully and effectively minimizes and clears pores on a long-term basis.

To learn where you can receive an Isolaz(TM) treatment or to receive more information on the Isolaz(TM) System please visit http://www.ISOLAZ.com.

About Aesthera Corporation

Aesthera (http://www.AESTHERA.com) develops, manufactures and markets light-based aesthetic treatment systems based on proprietary Photopneumatic(TM) (PPx(TM)) technology. Clinically proven to be pain-free and up to seven times faster than currently available light-based aesthetic systems, Aesthera's revolutionary systems combine the proven properties of therapeutic light with gentle pneumatic energy to more effectively work on dermal and epidermal skin targets.


'/>"/>
SOURCE Aesthera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. A New Home for Medical Breakthroughs
2. Yales Scassellati gets Microsoft breakthrough research award for robotics
3. Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment
4. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
5. Dental Convention to Highlight Latest Breakthroughs in Oral Health Treatments
6. Medical Breakthrough Reaches America
7. Tiny magnets offer breakthrough in gene therapy for cancer
8. New Breakthrough Treatment is Tough On Lice But Gentle On Kids
9. Key found to breakthrough drug for clot victims
10. Breakthrough Seating Technology, ergoSEET(TM), Now Available in Indianapolis
11. Breakthrough in birth-defect research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... from Germany, announced it is bringing its product to the United States as part ... perfected over the last 25 years, Alcovit aims to reduce the productions of nasty ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based ... recently attended the January ECRM Trade Show in Hilton Head, SC, benefiting from ... large range of supplements that keep the body functioning at its peak performance ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: